Literature DB >> 15477221

Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study.

François Lefrère, Alain Delmer, Vincent Levy, Richard Delarue, Bruno Varet, Olivier Hermine.   

Abstract

This study is a long-term follow-up analysis evaluating clinical outcome of patients with mantle-cell lymphoma treated by the sequential CHOP and DHAP chemotherapy followed by autografting. The median overall survival of 81 months (95% CI, 66-not reached) and the median event free survival of 51 months (95% CI, 43-not reached) confirm the improvement in outcome obtained by such protocol.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15477221

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  12 in total

Review 1.  Mantle cell lymphoma: observation to transplantation.

Authors:  Babak Rajabi; John W Sweetenham
Journal:  Ther Adv Hematol       Date:  2015-02

2.  Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.

Authors:  Christiane Pott; Eva Hoster; Marie-Helene Delfau-Larue; Kheira Beldjord; Sebastian Böttcher; Vahid Asnafi; Anne Plonquet; Reiner Siebert; Evelyne Callet-Bauchu; Niels Andersen; Jacques J M van Dongen; Wolfram Klapper; Françoise Berger; Vincent Ribrag; Achiel L van Hoof; Marek Trneny; Jan Walewski; Peter Dreger; Michael Unterhalt; Wolfgang Hiddemann; Michael Kneba; Hanneke C Kluin-Nelemans; Olivier Hermine; Elizabeth Macintyre; Martin Dreyling
Journal:  Blood       Date:  2009-12-23       Impact factor: 22.113

3.  The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma.

Authors:  S Robinson; P Dreger; D Caballero; P Corradini; C Geisler; M Ghielmini; S Le Gouill; E Kimby; S Rule; U Vitolo; M Dreyling; O Hermine
Journal:  Leukemia       Date:  2014-07-18       Impact factor: 11.528

4.  Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network.

Authors:  Vaishalee P Kenkre; Walter L Long; Jens C Eickhoff; Jules H Blank; Thomas A McFarland; Wayne Bottner; Hamied Rezazedeh; Jae E Werndli; Howard H Bailey; Brad S Kahl
Journal:  Leuk Lymphoma       Date:  2011-09

Review 5.  Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches.

Authors:  Bijal D Shah; Peter Martin; Eduardo M Sotomayor
Journal:  Cancer Control       Date:  2012-07       Impact factor: 3.302

6.  Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group.

Authors:  Rémy Gressin; Sylvie Caulet-Maugendre; Eric Deconinck; Olivier Tournilhac; Emmanuel Gyan; Marie Pierre Moles; Abderrazak El Yamani; Jerome Cornillon; Jean François Rossi; Steven Le Gouill; Gérard Lepeu; Ghandi Damaj; Philippe Solal Celigny; Hervé Maisonneuve; Bernadette Corront; Jean Pierre Vilque; Philippe Casassus; Thierry Lamy; Marc Colonna; Philippe Colombat
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

Review 7.  Controversies in the treatment of lymphoma with autologous transplantation.

Authors:  Alison J Moskowitz; Craig H Moskowitz
Journal:  Oncologist       Date:  2009-09-08

Review 8.  [Therapy of mantle cell lymphoma].

Authors:  M Dreyling; M Unterhalt; O Weigert; W Hiddemann
Journal:  Internist (Berl)       Date:  2007-04       Impact factor: 0.743

9.  Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.

Authors:  Brian G Till; Theodore A Gooley; Nathan Crawford; Ajay K Gopal; David G Maloney; Stephen H Petersdorf; John M Pagel; Leona Holmberg; William Bensinger; Oliver W Press
Journal:  Leuk Lymphoma       Date:  2008-06

10.  Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study.

Authors:  Morgane Cheminant; Coralie Derrieux; Aurore Touzart; Stéphanie Schmit; Adrien Grenier; Amélie Trinquand; Marie-Hélène Delfau-Larue; Ludovic Lhermitte; Catherine Thieblemont; Vincent Ribrag; Stéphane Cheze; Laurence Sanhes; Fabrice Jardin; François Lefrère; Richard Delarue; Eva Hoster; Martin Dreyling; Vahid Asnafi; Olivier Hermine; Elizabeth Macintyre
Journal:  Haematologica       Date:  2015-12-24       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.